Legacy Private Trust Co. Biogen Inc. Transaction History

Legacy Private Trust Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 09, 2021	SELL	$242.95 - $284.63 $267,730 - $313,662	-1,102 Closed	0 $0
Q4 2020 Jan 12, 2021	BUY	$236.26 - $355.63 $260,358 - $391,904	1,102 New	1,102 $270,000
Q1 2019 Apr 11, 2019	SELL	$216.71 - $338.96 $868,790 - $1.36 Million	-4,009 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $836,892 - $1.06 Million	-3,005 Reduced 42.84%	4,009 $1.21 Million
Q3 2018 Oct 10, 2018	BUY	$293.51 - $383.83 $57,821 - $75,614	197 Added 2.89%	7,014 $2.48 Million
Q2 2018 Jul 13, 2018	BUY	$257.52 - $306.91 $21,631 - $25,780	84 Added 1.25%	6,817 $1.98 Million
Q1 2018 Apr 13, 2018	BUY	$260.13 - $367.91 $398,259 - $563,270	1,531 Added 29.43%	6,733 $1.84 Million
Q4 2017 Jan 16, 2018	BUY	$307.64 - $344.58 $918,305 - $1.03 Million	2,985 Added 134.64%	5,202 $1.66 Million
Q3 2017 Oct 13, 2017	BUY	$281.15 - $329.69 $623,309 - $730,922	2,217	2,217 $694,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Legacy Private Trust Co., based on Form 13F filings with the SEC.

Stay updated on Legacy Private Trust Co. with notifications on news.